GSK
722 hedge funds and large institutions have $15.2B invested in GSK in 2014 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 325 increasing their positions, 215 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 712 → 722 (+10)
0.25% more ownership
Funds ownership: 4.43% → 4.67% (+0.25%)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
Holders
722
Holding in Top 10
9
Calls
$117M
Puts
$82.4M
Top Buyers
| 1 | +$387M | |
| 2 | +$263M | |
| 3 | +$110M | |
| 4 |
Renaissance Technologies
New York
|
+$99.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$83.1M |
Top Sellers
| 1 | -$215M | |
| 2 | -$147M | |
| 3 | -$71.2M | |
| 4 |
CLM
ClearBridge LLC (Maryland)
Baltimore,
Maryland
|
-$64.2M |
| 5 |
PP
PDT Partners
New York
|
-$19.3M |